Effect of SGLT2 inhibitors on cardiovascular events in patients with atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials.
Shiyue ZhengYi-Wei LaiChao JiangLiu HeZixu ZhaoWenjie LiRi-Bo TangCai-Hua SangDe-Yong LongXin DuChang Sheng MaJianzeng DongPublished in: Pacing and clinical electrophysiology : PACE (2023)
The treatment effects of SGLT2i were associated with a lower incidence of CV events, especially HF hospitalization, in patients with AF.